211 related articles for article (PubMed ID: 6801828)
21. Treatment of hyperviscosity syndrome in the patients with plasma cell dyscrasias.
Kes P; Pecanić Z; Getaldić B; Ratković-Gusić I
Acta Med Croatica; 1996; 50(4-5):173-7. PubMed ID: 9046114
[TBL] [Abstract][Full Text] [Related]
22. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.
Siami GA; Siami FS
Ther Apher; 1999 Feb; 3(1):8-19. PubMed ID: 10079800
[TBL] [Abstract][Full Text] [Related]
23. [Plasmapheresis and hyperviscosity syndrome].
Corral Alonso M; Barbolla ML
Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
[No Abstract] [Full Text] [Related]
24. Hyperviscosity syndrome in dysproteinemias.
Buxbaum J
Am J Med Sci; 1972 Aug; 264(2):123-6. PubMed ID: 4631633
[No Abstract] [Full Text] [Related]
25. Plasma volume expansion and increased serum viscosity in myeloma and macroglobulinaemia.
Tuddenham EG; Bradley J
Clin Exp Immunol; 1974 Feb; 16(2):169-76. PubMed ID: 4219875
[TBL] [Abstract][Full Text] [Related]
26. [Hyperviscosity syndrome and Waldenström's macroglobulinemia].
Shida M; Baba M; Sawada S
Nihon Rinsho; 1992 Jan; 50 Suppl():298-303. PubMed ID: 1578695
[No Abstract] [Full Text] [Related]
27. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
[TBL] [Abstract][Full Text] [Related]
28. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
[TBL] [Abstract][Full Text] [Related]
29. Experience with pre-diluted plasma exchange therapy for hyperviscosity syndrome.
Igarashi S; Kamikawa Y; Ono S; Maekawa G; Kishigami H; Kawamura K; Oonogi T; Nagano T
Ther Apher Dial; 2023 Dec; 27(6):1035-1039. PubMed ID: 37605348
[TBL] [Abstract][Full Text] [Related]
30. [Hyperviscosity syndrome].
Dumas G; Merceron S; Zafrani L; Canet E; Lemiale V; Kouatchet A; Azoulay E
Rev Med Interne; 2015 Sep; 36(9):588-95. PubMed ID: 25778852
[TBL] [Abstract][Full Text] [Related]
31. Blood viscosity in Waldenström macroglobulinemia.
MacKenzie MR; Lee TK
Blood; 1977 Apr; 49(4):507-10. PubMed ID: 402961
[TBL] [Abstract][Full Text] [Related]
32. [Lymphoplasmacytic lymphoma or multiple myeloma: immunoglobulins may lead to misdiagnosis].
Debus J; Lemaire P; Alani M; Farhi J; Rose J; Cussac V; Defasque S; Denizon N; Ghnaya H; Besançon-Bergelin A; Laribi K; Pineau-Vincent F
Ann Biol Clin (Paris); 2018 Aug; 76(4):451-457. PubMed ID: 30078781
[TBL] [Abstract][Full Text] [Related]
33. Serum viscosity and hyperviscosity syndrome in IGG multiple myeloma - the relationship of Sia test and to concentration of M component.
Pruzanski W; Russell ML
Am J Med Sci; 1976; 271(2):145-50. PubMed ID: 1266887
[TBL] [Abstract][Full Text] [Related]
34. Hyperviscosity syndrome in a patient with systemic lupus erythematosus.
Fukasawa T; Arai T; Naruse T; Maekawa T
Am J Med Sci; 1977; 273(3):329-34. PubMed ID: 868920
[TBL] [Abstract][Full Text] [Related]
35. The use of emergency apheresis in the management of plasma cell disorders.
Kalayoglu-Besisik S
Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
[TBL] [Abstract][Full Text] [Related]
36. Non-specific immune competence modulation following plasma exchange.
Busnach G; Brando B; Sommaruga E; Cappelleri A; Perrino ML; Dal Col A; Minetti L
Prog Clin Biol Res; 1990; 337():477-9. PubMed ID: 2141174
[No Abstract] [Full Text] [Related]
37. Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.
Abeykoon JP; Zanwar S; Ansell SM; Winters J; Gertz MA; King RL; Murray D; Habermann T; Dingli D; Muchtar E; Go RS; Leung N; Inwards DJ; Buadi FK; Dispenzieri A; Lacy MQ; Lin Y; Gonsalves WI; Kourelis T; Witzig TE; Thompson C; Vincent Rajkumar S; Kyle RA; Kumar S; Kapoor P
Am J Hematol; 2018 Nov; 93(11):1384-1393. PubMed ID: 30121949
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of hyperviscosity in monoclonal gammopathies.
Crawford J; Cox EB; Cohen HJ
Am J Med; 1985 Jul; 79(1):13-22. PubMed ID: 4014299
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of plasmapheresis in symptomatic hyperviscosity and cast nephropathy: A Multicenter Experience in Turkey.
Kalpakci Y; Hacibekiroglu T; Darcin T; AkgunCagliyan G; Cakar MK; Hacioglu SK; Ekinci O; Korkmaz S; Albayrak M; Dal MS; Dogan A; Ulas T; Eser B; Altuntas F
Transfus Apher Sci; 2021 Oct; 60(5):103244. PubMed ID: 34462219
[TBL] [Abstract][Full Text] [Related]
40. Immunochemical and clinical characteristic of series of 516 paraproteinemic patients.
Tichý M; Hrncir Z; Mracek J; Hrncirová L; Matĕja F
Neoplasma; 1978; 25(4):477-81. PubMed ID: 99675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
